- Report
- January 2026
- 191 Pages
Global
From €3196EUR$3,545USD£2,746GBP
€3551EUR$3,939USD£3,051GBP
- Report
- September 2026
- 384 Pages
Global
From €5273EUR$5,850USD£4,531GBP
- Report
- January 2026
- 289 Pages
Global
From €2254EUR$2,500USD£1,936GBP
- Report
- June 2026
- 120 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- June 2026
- 255 Pages
Global
From €4322EUR$4,795USD£3,714GBP
- Report
- February 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- January 2026
- 184 Pages
Global
From €3196EUR$3,545USD£2,746GBP
€3551EUR$3,939USD£3,051GBP
- Report
- February 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- July 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- February 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- July 2026
- 180 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- August 2026
- 160 Pages
Global
From €2993EUR$3,320USD£2,571GBP
€3741EUR$4,150USD£3,214GBP
- Report
- August 2026
- 160 Pages
Global
From €2993EUR$3,320USD£2,571GBP
€3741EUR$4,150USD£3,214GBP
- Report
- June 2026
- 100 Pages
Africa, Middle East
From €3421EUR$3,795USD£2,939GBP
- Report
- June 2026
United States
From €2254EUR$2,500USD£1,936GBP
- Report
- September 2022
- 194 Pages
Global
From €4326EUR$4,799USD£3,717GBP
- Report
- August 2025
- 191 Pages
Global
From €3196EUR$3,545USD£2,746GBP
€3551EUR$3,939USD£3,051GBP
- Report
- September 2025
Global
From €4417EUR$4,900USD£3,795GBP
- Report
- March 2024
- 200 Pages
Global
From €3741EUR$4,150USD£3,214GBP
- Report
- March 2024
- 120 Pages
Global
From €4056EUR$4,500USD£3,485GBP

The Cytomegalovirus Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat cytomegalovirus (CMV) infections, a type of virus that can cause serious health problems in people with weakened immune systems. These drugs are used to reduce the severity of symptoms, prevent complications, and reduce the risk of transmission. Commonly used drugs include ganciclovir, valganciclovir, and foscarnet.
The Cytomegalovirus Drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include Gilead Sciences, Merck & Co., Pfizer, Novartis, and GlaxoSmithKline. Show Less Read more